Abstract
New York is at the epicenter of the coronavirus disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2 virus. Columbia University Irving Medical Center/NewYork-Presbyterian Hospital (CUIMC/NYPH) had to make changes to its cellular therapy operations to ensure patient, donor, and staff safety and well-being. In this article, we discuss the process changes we instituted for cellular therapy clinical care, collection, processing, and cryopreservation to cope with the rapidly evolving pandemic.
Cite
CITATION STYLE
Tanhehco, Y. C., & Schwartz, J. (2020). How the COVID-19 pandemic changed cellular therapy at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital. Transfusion, 60(9), 1905–1909. https://doi.org/10.1111/trf.15956
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
